← The Wire
HROWNasdaq
HARROW, INC.
Pharmaceutical Preparations · DE · CIK 1360214
Harrow, Inc. provides branded ophthalmic disease management solutions and medications for eyecare professionals and patients
$1.40B
Market cap
$41.15
Last close
-2.2%
1D
-3.0%
5D
483K
Volume
Price · last 39 sessions+2.4%
May 4L $29.03 · H $42.87Jun 29
419
Total filings
Jun 22, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 22, 20268-KReg FD DisclosureJun 3, 202610-Q10-QMay 11, 20268-KResults of Operations · Reg FD DisclosureMay 11, 2026DEFA14ADEFA14AApr 24, 2026DEF 14ADEF 14AApr 24, 20268-KMaterial Agreement · New Debt / ObligationMar 27, 20268-KCompany UpdateMar 24, 20268-KCompany UpdateMar 24, 20268-KReg FD DisclosureMar 10, 202610-K10-KMar 2, 20268-KResults of Operations · Reg FD DisclosureMar 2, 20268-KExecutive Change · Results of OperationsFeb 2, 20268-KAcquisition / Disposition · Equity IssuanceNov 18, 202510-Q10-QNov 10, 20258-KResults of Operations · Reg FD DisclosureNov 10, 20258-KExecutive Change · Reg FD DisclosureOct 6, 20258-K/ACompany UpdateOct 1, 20258-KMaterial Agreement · New Debt / ObligationSep 29, 20258-KReg FD DisclosureSep 26, 20258-KMaterial Agreement · Equity IssuanceSep 26, 20258-KAuditor ChangeSep 19, 20258-KMaterial Agreement · New Debt / ObligationSep 12, 20258-KCompany UpdateSep 9, 20258-KMaterial Agreement · New Debt / ObligationSep 8, 20258-KExecutive Change · Bylaw AmendmentAug 25, 202510-Q10-QAug 11, 20258-KResults of Operations · Reg FD DisclosureAug 11, 20258-KCompany UpdateJul 17, 20258-KShareholder VoteJun 20, 20258-KCompany UpdateJun 9, 202510-Q10-QMay 8, 20258-KResults of OperationsMay 8, 2025DEFA14ADEFA14AApr 25, 2025DEF 14ADEF 14AApr 25, 202510-K10-KMar 27, 20258-KResults of OperationsMar 27, 20258-KResults of OperationsMar 17, 20258-KExecutive ChangeJan 21, 202510-Q10-QNov 14, 20248-KResults of OperationsNov 14, 20248-KMaterial Agreement · New Debt / ObligationOct 28, 20248-KReg FD DisclosureSep 9, 202410-Q10-QAug 7, 20248-KResults of OperationsAug 7, 20248-KAuditor ChangeJun 26, 20248-KShareholder VoteJun 17, 202410-Q10-QMay 13, 20248-KResults of OperationsMay 13, 2024DEFA14ADEFA14AApr 26, 2024DEF 14ADEF 14AApr 26, 20248-KCompany UpdateMar 21, 20248-KCompany UpdateMar 20, 20248-KResults of Operations · Reg FD DisclosureMar 19, 202410-K10-KMar 19, 20248-KCompany UpdateFeb 15, 2024SC 13GSCHEDULE 13GFeb 13, 20248-KExecutive ChangeJan 29, 2024SC 13GSC 13GJan 29, 2024SC 13GSC 13GJan 9, 20248-KExecutive Change · Agreement TerminatedJan 3, 2024SC 13GSCHEDULE 13GNov 24, 202310-Q10-QNov 13, 20238-KResults of OperationsNov 13, 20238-KExecutive ChangeNov 3, 20238-KBylaw AmendmentSep 29, 202310-Q10-QAug 9, 20238-KResults of OperationsAug 9, 20238-KMaterial Agreement · Reg FD DisclosureJul 21, 2023424B5424B5Jul 19, 2023424B5424B5Jul 18, 20238-KMaterial Agreement · Results of OperationsJul 18, 20238-KShareholder VoteJun 23, 202310-Q10-QMay 11, 20238-KResults of Operations · Reg FD DisclosureMay 11, 2023DEFA14ADEFA14AApr 28, 2023DEF 14ADEF 14AApr 28, 20238-KMaterial Agreement · Agreement TerminatedMar 28, 202310-K10-KMar 23, 20238-KResults of OperationsMar 23, 2023
Insider Activity
In the 90 days to Mar 4, 2026: 1 sold $9.2M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 2026 | Opaleye Management Inc.TenPercentOwner | Sell | 134,000 | $39.67 | $5.3M |
| Mar 4, 2026 | Opaleye Management Inc.TenPercentOwner | Sell | 4,263 | $39.67 | $169K |
| Mar 3, 2026 | Opaleye Management Inc.TenPercentOwner | Sell | 59,000 | $39.15 | $2.3M |
| Mar 3, 2026 | Opaleye Management Inc.TenPercentOwner | Sell | 1,309 | $39.15 | $51K |
| Feb 27, 2026 | Opaleye Management Inc.TenPercentOwner | Sell | 5,000 | $54.18 | $271K |
| Jan 6, 2026 | Opaleye Management Inc.TenPercentOwner | Sell | 20,000 | $53.35 | $1.1M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance